280 related articles for article (PubMed ID: 25759549)
1. Prolonged overall survival in gastric cancer patients after adoptive immunotherapy.
Zhang GQ; Zhao H; Wu JY; Li JY; Yan X; Wang G; Wu LL; Zhang XG; Shao Y; Wang Y; Jiao SC
World J Gastroenterol; 2015 Mar; 21(9):2777-85. PubMed ID: 25759549
[TBL] [Abstract][Full Text] [Related]
2. Adoptive immunotherapy for small cell lung cancer by expanded activated autologous lymphocytes: a retrospective clinical analysis.
Zhang GQ; Li F; Sun SJ; Hu Y; Wang G; Wang Y; Cui XX; Jiao SC
Asian Pac J Cancer Prev; 2015; 16(4):1487-94. PubMed ID: 25743819
[TBL] [Abstract][Full Text] [Related]
3. Immune modulation and safety profile of adoptive immunotherapy using expanded autologous activated lymphocytes against advanced cancer.
Sun Z; Shi L; Zhang H; Shao Y; Wang Y; Lin Y; Li X; Bai C
Clin Immunol; 2011 Jan; 138(1):23-32. PubMed ID: 21041120
[TBL] [Abstract][Full Text] [Related]
4. Adoptive immunotherapy for non-small cell lung cancer by NK and cytotoxic T lymphocytes mixed effector cells: retrospective clinical observation.
Zhang G; Zhao H; Wu J; Li J; Xiang Y; Wang G; Wu L; Jiao S
Int Immunopharmacol; 2014 Aug; 21(2):396-405. PubMed ID: 24881900
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
Gastroenterology; 2015 Jun; 148(7):1383-91.e6. PubMed ID: 25747273
[TBL] [Abstract][Full Text] [Related]
6. Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients.
Jiang JT; Shen YP; Wu CP; Zhu YB; Wei WX; Chen LJ; Zheng X; Sun J; Lu BF; Zhang XG
World J Gastroenterol; 2010 Dec; 16(48):6155-62. PubMed ID: 21182234
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of adoptive cellular therapy in patients with gastric cancer: a meta-analysis.
Shen D; Liu ZH; Xu JN; Xu F; Lin QF; Lin F; Mao WD
Immunotherapy; 2016 Jul; 8(8):971-81. PubMed ID: 27381688
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion.
Song QK; Ren J; Zhou XN; Wang XL; Song GH; Di LJ; Yu J; Hobeika A; Morse MA; Yuan YH; Yang HB; Lyerly HK
Oncotarget; 2015 Dec; 6(38):41350-9. PubMed ID: 26462021
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells.
Jiang J; Xu N; Wu C; Deng H; Lu M; Li M; Xu B; Wu J; Wang R; Xu J; Nilsson-Ehle P
Anticancer Res; 2006; 26(3B):2237-42. PubMed ID: 16821594
[TBL] [Abstract][Full Text] [Related]
10. Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer.
Li Y; Wang C; Xu M; Kong C; Qu A; Zhang M; Zheng Z; Zhang G
J Cancer Res Clin Oncol; 2017 May; 143(5):861-871. PubMed ID: 28108815
[TBL] [Abstract][Full Text] [Related]
11. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
[TBL] [Abstract][Full Text] [Related]
12. Which has the least immunity depression during postoperative analgesia--morphine, tramadol, or tramadol with lornoxicam?
Wang ZY; Wang CQ; Yang JJ; Sun J; Huang YH; Tang QF; Qian YN
Clin Chim Acta; 2006 Jul; 369(1):40-5. PubMed ID: 16487501
[TBL] [Abstract][Full Text] [Related]
13. The importance of T-lymphocyte subsets on overall survival of colorectal and gastric cancer patients.
Milasiene V; Stratilatovas E; Norkiene V
Medicina (Kaunas); 2007; 43(7):548-54. PubMed ID: 17768369
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of activated lymphocytes transfer therapy as a novel maker for serum granulysin level with advanced gastric cancer patients].
Kato Y; Cyon JC; Yoshimatsu K; Ogawa K
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2262-4. PubMed ID: 19106590
[TBL] [Abstract][Full Text] [Related]
15. Tumor MICA status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer.
Chen Y; Lin WS; Zhu WF; Lin J; Zhou ZF; Huang CZ; Chen G; Shi Y; Guo ZQ; Ye YB
Immunol Res; 2016 Feb; 64(1):251-9. PubMed ID: 26607264
[TBL] [Abstract][Full Text] [Related]
16. Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells.
Kim YJ; Lim J; Kang JS; Kim HM; Lee HK; Ryu HS; Kim JY; Hong JT; Kim Y; Han SB
Arch Pharm Res; 2010 Nov; 33(11):1789-95. PubMed ID: 21116782
[TBL] [Abstract][Full Text] [Related]
17. [Cellular immunotherapy for local recurrence of rectal cancer after surgery by activated lymphocyte administration--a case report].
Sasatomi T; Toh U; Miyagi Y; Ishibashi N; Araki Y; Ogata Y; Yamana H; Shirouzu K
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1692-5. PubMed ID: 11708011
[TBL] [Abstract][Full Text] [Related]
18. [Clinical application of adoptive immunotherapy by cytotoxic T lymphocytes induced from tumor-infiltrating lymphocytes].
Yamaue H; Tanimura H; Tsunoda T; Iwahashi M; Tani M; Inoue M; Tamai M
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):978-89. PubMed ID: 2391445
[TBL] [Abstract][Full Text] [Related]
19. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
[TBL] [Abstract][Full Text] [Related]
20. A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma.
Leemhuis T; Wells S; Scheffold C; Edinger M; Negrin RS
Biol Blood Marrow Transplant; 2005 Mar; 11(3):181-7. PubMed ID: 15744236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
